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ABSTRACT
Background: Oxidative stress, the imbalance between pro- and antioxidants, has been implicated in the etiology and
pathophysiology of the incidence and mortality of many diseases. We aim to investigate the relations of dietary intakes of
vitamin C and E and main carotenoids with all-cause mortality in Japanese men and women.
Methods: The Japan Collaborative Cohort Study for Evaluation of Cancer Risk had 22,795 men and 35,539 women, aged 40–79
years at baseline (1988–1990), who completed a valid food frequency questionnaire and were followed up to the end of 2009.
Results: There were 6,179 deaths in men and 5,355 deaths in women during the median follow-up of 18.9 years for men and
19.4 years for women. Multivariate hazard ratios for the highest versus lowest quintile intakes in women were 0.83 (95%
conﬁdence interval [CI], 0.76–0.90; P for trend < 0.0001) for vitamin C, 0.85 (95% CI, 0.78–0.93; P for trend < 0.0001) for
vitamin E, 0.88 (95% CI, 0.81–0.96; P for trend = 0.0006) for β-carotene, and 0.90 (95% CI, 0.82–0.98; P for trend = 0.0002)
for β-cryptoxanthin. The joint eﬀect of any two of these highly correlated micronutrients showed signiﬁcant 12–17% reductions
in risk in the high-intake group compared with the low-intake group in women. These signiﬁcant associations were also
observed in the highest quintile intakes of vitamin C, vitamin E, and β-carotene in female non-smokers but were not observed in
female smokers, male smokers, and non-smokers.
Conclusions: Higher dietary intakes of antioxidant vitamins may reduce the risk of all-cause mortality in middle-aged Japanese
women, especially female non-smokers.
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Copyright © 2018 Enbo Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
INTRODUCTION
Oxidative stress, the imbalance between pro- and antioxidants,
has been implicated in the etiology, pathophysiology, and
increased incidence of many chronic diseases and mortality.1,2
Vitamin C, vitamin E, and carotenoids are essential antioxidants
in diet and may prevent oxidative damages by free radicals.3–5
Observational studies in populations reported that higher dietary
intake of vitamin C,6–9 vitamin E,10 and carotenoids,7,8,10 or
greater balance of antioxidant scores4,11 have been associated
with decreased risk of all-cause mortality; however, these
relationships were not conﬁrmed in many studies for individual
dietary nutrients, such as vitamin C,2,5,10,12,13 vitamin E,5,7,12,13
and β-carotene.5,12,13 In addition, smokers can be at risk for anti-=
pro-oxidant imbalances of body tissues due to the excessive
oxidants and free radicals from cigarette smoke.11
Fewer studies have been carried out to measure the association
between antioxidants and the risk of all-cause mortality in Asian
populations.9 Antioxidants and other micronutrients are rich in
Japanese foods, such as fruits, vegetables, and green tea.14 The
JACC Study reported that higher dietary intake of potatoes,
spinach, or garland chrysanthemums was associated with reduced
risk of all-cause mortality in both men and women, and that
higher intake of carrot or pumpkin was associated with reduced
risk of all-cause mortality in women.15 Favorable eﬀects of fruits
and vegetables could in part be driven by high antioxidant
nutrients.16 The JACC Study also reported inverse associations
of dietary vitamin C and E intakes with mortality from
cardiovascular disease (CVD).14 Although that report did not
include carotenoids, serum beta-carotene was associated with
cancer and all-cause mortality in a subpopulation of the JACC
Study.17,18 In spite of these reports, the overall association
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between dietary nutrients and all-cause mortality has not been
comprehensively examined in the JACC Study. In this report,
we aim to assess the relations of individual dietary intakes of
antioxidant nutrients, namely vitamin C, vitamin E, and main
carotenoids, as well as additive or synergistic properties in the
combination of them, with all-cause mortality in Japanese men
and women. Furthermore, we examined eﬀect modiﬁcation by
smoking in groups deﬁned according to dietary micronutrient
intakes.
METHODS
Study cohort
The JACC Study is a cohort study that comprised a nationwide
community-based sample of 110,585 persons (46,395 men and
64,190 women), aged 40 to 79 years during the baseline period
(1988–1990), from 45 communities of Japan. Participants
completed self-administered questionnaires about their lifestyles
and medical histories of previous CVD or cancer. Previous
publications have described the methods in detail.19,20 In this
study, we excluded persons who reported a history of CVD or
cancer at baseline (2,488 men and 3,187 women). We further
excluded those with incomplete answers for the foods mainly
contributing to dietary intakes in the food frequency questionnaire
(FFQ) (20,742 men and 25,386 women) and those answers with
implausibly high or low total energy intakes (370 men with
energy intake <800 or >4,000 kcal=d and 78 women with energy
intake <500 or >3,500 kcal=d).21 Ultimately, we included 22,795
eligible men and 35,539 eligible women from 45 communities
in this study. The JACC Study was approved by the Ethics
Boards at the Osaka University School of Medicine and the
Nagoya University School of Medicine. Informed consents were
obtained before participants completed the questionnaire or from
community leaders instead of individuals.20
Mortality
In each community, investigators conducted a systematic review
of death certiﬁcates through the end of 2009, except in four areas
where the follow-up had ended in 1999, another four areas where
follow-up ended in 2003, and two areas where follow-up ended in
2008. In Japan, registration of death is legally required and is
considered to be followed across Japan. In this cohort, all deaths
occurred were ascertained by death certiﬁcates from a public
health center, except for those who died after they had moved
from their original communities, which were treated as censored
when they moved out. The date of moving from the community
was veriﬁed by population-register sheets. In total, there were
1,166 (5.1%) men and 2,191 (6.2%) women moved out of study
areas during the follow-up period.
Baseline questionnaire
The FFQ included 33 food items, with ﬁve choices for frequency
of intake oﬀered for each item.22 The amount of vitamin C,
vitamin E, and main carotenoids that each food item contained
was estimated based on the enlarged ﬁfth version of the Japan
Food Table.23 The amount of antioxidant nutrients were then
calculated by multiplying the frequency scores by the estimated
intakes of vitamin C (ascorbic acids), vitamin E (α-tocopherol),
and carotenes from each food and summing across all 33 items,
as has been validated previously.22 Intakes of tested antioxidant
nutrients were adjusted for energy intake using the nutrient
residual model.24 The mean energy-adjusted intake of vitamin C
was underestimated by 30%, according to the validation study
that compared them with dietary records in a subsample (n = 85,
mostly female).22 Spearman’s correlation coeﬃcient between
vitamin C derived from the FFQ and dietary records was 0.38 for
crude intake and 0.27 for energy-adjusted intake.22
Statistical analysis
Person-years of follow-up were counted from the date of the
survey until the time of death, the date of moving out of a study
area, or the end of 2009, whichever came ﬁrst. The mortality rates
were calculated according to quintile intakes of energy-adjusted
nutrients based on men and women cohorts, separately. Spearman
correlations were performed to assess the collinearity among
covariates, and participants’ characteristics were shown according
to quintiles of vitamin C intake. Hazard ratios (HRs) with 95%
conﬁdence intervals (CIs) were computed with adjustment for age
and other potential risk factors with Cox proportional hazards
models, using the lowest quintile intake group as reference. The
confounding factors included baseline body mass index (BMI;
<20, 20 to <25, 25 to <30, and ≥30 kg=m2), smoking (never,
former, current <20 cigarettes=d, and current ≥20 cigarettes=d),
alcohol drinking (never, former, and current), daily walking time
(never, 30min to <1 h, and ≥1 h), weekly physical activity (never,
1–2, and ≥3 h), education years (<6, 6–10, 11–13, and >13 y),
daily vitamin supplement using (no or yes), and menopausal
status (no or yes [for women only]). Interaction was tested by
including the factors of interest and the cross-product term in
multivariate models.25 Associations of joint intakes of studied
antioxidants with risk of all-cause mortality were measured using
cross-products of tertile intakes of two antioxidants, which were
categorized as low (both in tertile 1), intermediate (both in varying
tertiles), and high (both in tertile 3).26 We ascertained dose-
response trends by assigning median values to each exposure
category and modeling these variables as continuous variables.27
Stratiﬁed analysis was performed for smoking status (current,
former, and never) in participants. We used SAS version 9.4 (SAS
Institute Inc, Cary, NC, USA) for the analyses. All probability
values for statistical tests were two-tailed, and P values less than
0.05 were considered statistically signiﬁcant.
RESULTS
For tracking intakes of antioxidants, baseline characteristics of
covariates in the study population were presented according to
the energy-adjusted quintile intakes of vitamin C in Table 1.
Smoking, alcohol consumption, weekly physical activities, and
education level were higher in men than in women, while dietary
intake of vitamin C, daily vitamin supplement use, and intakes
of vegetable and fruit were higher in women than in men. Both
in men and women, the vitamin C amount increased as intakes
of vegetables and fruits increased. As the intake of vitamin C
increased, the population of current smokers in men was
decreased while the population of former smokers in men was
slightly increased. Similar situations for current male smokers
were observed according to other vitamins (data not shown).
During a median follow-up of 18.9 years for 22,795 men and 19.4
years for 35,539 women, 6,179 and 5,355 deaths in men and
women, respectively, were documented.
Table 2 shows the ranges and medians of dietary intake of
antioxidant micronutrients, the number of deaths, followed
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person-years, and the associations between individual antioxidant
nutrient intake and all-cause mortality in men and women,
respectively. Comparing with women, men had lower intakes of
vitamin C, α-carotene, β-carotene, and β-cryptoxanthin for each
quintile. The correlation coeﬃcients among vitamin C, vitamin E,
α-carotene, and β-carotene (not shown in tables) ranged from
0.57–0.85 in men and from 0.52–0.84 in women, and the
correlation coeﬃcient between vitamin C and β-cryptoxanthin
was 0.73 in men and 0.72 in women; lower coeﬃcients were seen
between β-cryptoxanthin and vitamin E (0.33 in men and 0.27
in women), α-carotene (0.17 in men and 0.11 in women), and
β-carotene (0.24 in men and 0.18 in women).
In the age-adjusted model, higher intakes of vitamin C and
β-cryptoxanthin were inversely associated with mortality risk in
men, with statistically signiﬁcant trends. In multivariate analysis,
these associations were attenuated without reaching the
signiﬁcance level in the highest quintile (P for trend > 0.05).
The association between β-cryptoxanthin intake and all-cause
mortality showed a U-shape, with signiﬁcant lower risk in the
intermediate quintiles. In both age-adjusted and multivariate
models, the dietary intakes of vitamin C, vitamin E, β-carotene,
and β-cryptoxanthin among women were signiﬁcantly associated
with mortality risk, with 10–17% reductions in the ﬁfth quintile
compared with the ﬁrst quintile of intakes (Table 2). When we
added the dietary intake of fat for adjustment, the associations
between studied nutrients and all-cause mortality risk were not
altered (data not shown).
There were no statistically signiﬁcant interactions eﬀects
observed between smoking and alcohol drinking, or between
smoking or alcohol drinking and any micronutrients, by adding
the cross-product in the univariate and multivariate models.
Similarly, there were no signiﬁcant interaction eﬀects on all-cause
mortality (P > 0.05) observed for any two of individual nutrients
when simultaneously including them with their interaction term in
the models. Therefore, Table 3 shows results of main eﬀects from
combined categories of two individual nutrients without the
interaction term. For the nutrient-mortality associations based on
their joint intakes, we observed 3–6% lower risk in the highest vs
lowest categories of combined intakes of any two of vitamin C
and carotenes in men and 12–17% lower risk in the highest vs
lowest categories of combined intakes of any two of vitamin C, E,
α-carotene, β-carotene, and β-cryptoxanthin (with distinctively
signiﬁcant trends) in women (Table 3).
For intensive control of smoking eﬀect, we also conducted
stratiﬁed analysis by smoking status, and there were no signiﬁcant
associations observed in male current, former, or never smokers
(Table 4). However, statistically signiﬁcant HRs were seen in the
highest compared with the lowest quintiles of vitamin C, vitamin
E, and β-carotene in female nonsmokers, but not in female former
and current smokers (Table 5). Similar estimates were obtained
when results were stratiﬁed by alcohol drinking (current, former,
and never) or BMI (<25 and ≥25 kg=m2): the only signiﬁcantly
reduced risks were observed in female nondrinker or women with
BMI <25 kg=m2. In female nondrinkers, reduced mortality risk
Table 1. Baseline characteristics of study population according to the energy-adjusted intake of vitamin C, JACC Study, 1988–1990
Characteristics
Quintiles of energy-adjusted intake of vitamin Ca
Q1 (lower) Q2 Q3 Q4 Q5
Men, n 4,559 4,559 4,559 4,559 4,559
Energy-adjusted vitamin C, median, mg=d 53 76 94 113 143
Age, years 54 (9.7) 55 (9.7) 55.8 (9.7) 56.8 (9.9) 58.1 (10.0)
BMI, kg=m2 22.7 (2.8) 22.7 (2.8) 22.7 (2.7) 22.7 (2.7) 22.7 (2.8)
Former smoker, % 21.9 23.0 24.6 25.8 26.2
Current smoker, % 58.9 54.6 52.7 50.1 47.4
Current drinker, % 77.9 76.9 76.5 75.1 71.7
Weekly physical activity ≥3 h, % 4.9 5.9 7.0 8.0 8.5
Daily walk ≥1 h, % 43.9 46.0 47.9 48.3 49.1
College education and above, % 14.1 15.8 16.7 18.6 19.3
Daily use of vitamin supplement, % 7.7 7.4 7.7 8.8 9.4
Daily dietary intake
Total energy, kcal 1,771 (485) 1,805 (483) 1,812 (483) 1,812 (500) 1,708 (474)
Vegetable, g 47 (27) 73 (35) 91 (41) 112 (48) 145 (55)
Fruit, g 43 (36) 80 (49) 113 (61) 154 (71) 209 (80)
Women, n 7,107 7,108 7,108 7,108 7,108
Energy-adjusted vitamin C, median, mg=d 65 89 106 123 149
Age, years 55.4 (10.1) 55.4 (9.9) 56.2 (9.8) 56.6 (9.7) 57.8 (9.6)
BMI, kg=m2 23.0 (3.2) 22.9 (3.1) 22.9 (3.1) 22.9 (3.0) 23.0 (3.0)
Former smoker, % 1.3 1.3 1.2 1.2 1.4
Current smoker, % 6.3 4.6 3.8 3.8 4.0
Current drinker, % 23.2 22.6 22.6 22.0 21.3
Weekly physical activity ≥3 h, % 3.5 3.9 4.1 4.7 5.0
Daily walk ≥1 h, % 45.7 46.0 48.2 49.9 49.9
College education and above, % 7.1 9.0 10.2 11.0 11.6
Daily use of vitamin supplement, % 8.4 9.2 10.8 10.5 10.8
Daily dietary intake
Total energy, kcal 1,416 (393) 1,447 (365) 1,442 (351) 1,450 (346) 1,391 (360)
Vegetable, g 62 (32) 89 (38) 105 (43) 125 (49) 153 (54)
Fruit, g 63 (43) 111 (55) 146 (62) 183 (70) 233 (76)
BMI, body mass index.
aNumbers are mean (SD) unless speciﬁed otherwise.
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Table 2. Ranges of energy-adjusted dietary antioxidant nutrients at baseline and hazard ratios for all-cause mortality during follow-up time
in men and women, JACC Study
Quintiles intakes of dietary antioxidant nutrients
P, trend
Q1 (lower) Q2 Q3 Q4 Q5
Men
Vitamin C
Range, mg=d <67 67–85 85–104 104–126 >126
Median, mg=d 54 76 94 114 143
Person-years 72,892 74,580 74,285 73,517 72,795
Number of deaths 1,093 1,143 1,188 1,277 1,478
Age-adjusted HR (95% CI) 1 0.89 (0.82, 0.97) 0.87 (0.80, 0.94) 0.86 (0.79, 0.93) 0.89 (0.83, 0.97) 0.016
Multivariate HR (95% CI)a 1 0.93 (0.86, 1.01) 0.93 (0.86, 1.01) 0.94 (0.87, 1.02) 0.97 (0.90, 1.05) 0.011
Vitamin E
Range, mg=d <4.1 4.1–4.7 4.7–5.3 5.3–6 >6
Median, mg=d 3.7 4.4 5 5.6 6.5
Person-years 73,343 74,884 74,602 73,918 71,320
Number of deaths 1,039 1,079 1,154 1,324 1,583
Age-adjusted HR (95% CI) 1 0.90 (0.83, 0.98) 0.89 (0.82, 0.97) 0.92 (0.85, 1.00) 0.97 (0.90, 1.05) 0.907
Multivariate HR (95% CI)a 1 0.98 (0.90, 1.07) 0.99 (0.91, 1.08) 1.03 (0.94, 1.12) 1.03 (0.95, 1.13) 0.808
α-carotene
Range, µg=d <164 164–226 226–295 295–397 >397
Median, µg=d 122 196 258 338 494
Person-years 72,361 74,079 74,374 74,059 73,195
Number of deaths 985 1,089 1,183 1,381 1,541
Age-adjusted HR (95% CI) 1 0.94 (0.87, 1.03) 0.94 (0.87, 1.03) 0.98 (0.91, 1.07) 1.00 (0.92, 1.08) 0.378
Multivariate HR (95% CI)a 1 0.98 (0.90, 1.07) 0.99 (0.91, 1.08) 1.03 (0.94, 1.12) 1.03 (0.95, 1.13) 0.789
β-carotene
Range, µg=d <1,301 1,301–1,782 1,782–2,294 2,294–2,959 >2,959
Median, µg=d 1,139 1,739 2,291 2,918 3,892
Person-years 73,480 74,899 74,154 74,103 71,432
Number of deaths 982 1,112 1,224 1,287 1,574
Age-adjusted HR (95% CI) 1 0.98 (0.90, 1.06) 0.97 (0.89, 1.05) 0.92 (0.84, 1.00) 0.98 (0.91, 1.07) 0.574
Multivariate HR (95% CI)a 1 1.02 (0.94, 1.11) 1.02 (0.93, 1.11) 0.97 (0.89, 1.06) 1.04 (0.95, 1.13) 0.309
β-cryptoxanthin
Range, µg=d <215 215–408 408–658 658–966 >966
Median, µg=d 101 307 519 807 1,206
Person-years 73,355 74,703 73,840 74,049 72,121
Number of deaths 1,292 1,184 1,184 1,217 1,302
Age-adjusted HR (95% CI) 1 0.87 (0.80, 0.94) 0.84 (0.77, 0.91) 0.83 (0.76, 0.89) 0.89 (0.83, 0.97) 0.017
Multivariate HR (95% CI)a 1 0.92 (0.85, 0.99) 0.89 (0.82, 0.96) 0.88 (0.81, 0.95) 0.97 (0.90, 1.05) 0.028
Women
Vitamin C
Range, mg=d <78 78–97 97–114 114–134 >134
Median, mg=d 65 88 106 123 149
Person-years 116,969 118,072 118,656 119,845 120,213
Number of deaths 1,094 967 1,063 1,059 1,172
Age-adjusted HR (95% CI) 1 0.87 (0.80, 0.95) 0.86 (0.79, 0.94) 0.81 (0.75, 0.88) 0.80 (0.74, 0.87) <0.0001
Multivariate HR (95% CI)a 1 0.89 (0.82, 0.97) 0.88 (0.81, 0.96) 0.84 (0.77, 0.92) 0.83 (0.76, 0.90) <0.0001
Vitamin E
Range, mg=d <4.2 4.2–4.8 4.8–5.3 5.3–5.9 >5.9
Median, mg=d 3.8 4.6 5.1 5.6 6.4
Person-years 116,019 118,768 119,651 119,465 119,852
Number of deaths 1,075 976 1,043 1,070 1,191
Age-adjusted HR (95% CI) 1 0.90 (0.83, 0.99) 0.88 (0.80, 0.95) 0.84 (0.78, 0.92) 0.83 (0.76, 0.90) <0.0001
Multivariate HR (95% CI)a 1 0.92 (0.84, 1.01) 0.91 (0.84, 1.00) 0.88 (0.81, 0.96) 0.85 (0.78, 0.93) <0.0001
α-carotene
Range, µg=d <191 191–262 262–338 338–456 >456
Median, µg=d 150 226 300 384 541
Person-years 113,093 118,785 119,628 120,736 121,512
Number of deaths 924 984 1,013 1,154 1,280
Age-adjusted HR (95% CI) 1 0.95 (0.86, 1.03) 0.91 (0.83, 1.00) 0.92 (0.84, 1.00) 0.92 (0.84, 1.00) 0.084
Multivariate HR (95% CI)a 1 0.95 (0.87, 1.04) 0.93 (0.85, 1.02) 0.93 (0.85, 1.02) 0.93 (0.85, 1.02) 0.033
β-carotene
Range, µg=d <1,709 1,709–2,287 2,287–2,855 2,855–3,569 >3,569
Median, µg=d 1,363 1,999 2,565 3,180 4,096
Person-years 116,017 118,952 119,937 120,061 118,788
Number of deaths 992 925 1,067 1,058 1,313
Age-adjusted HR (95% CI) 1 0.85 (0.78, 0.93) 0.88 (0.81, 0.96) 0.78 (0.71, 0.85) 0.86 (0.79, 0.94) 0.0008
Multivariate HR (95% CI)a 1 0.86 (0.78, 0.94) 0.90 (0.83, 0.99) 0.82 (0.75, 0.89) 0.88 (0.81, 0.96) 0.0006
β-cryptoxanthin
Range, µg=d <327 327–581 581–841 840–1,101 >1,101
Median, µg=d 204 450 731 953 1,342
Person-years 120,305 119,626 120,141 118,247 115,436
Number of deaths 1,174 1,104 1,054 1,040 983
Age-adjusted HR (95% CI) 1 0.95 (0.88, 1.04) 0.87 (0.80, 0.94) 0.86 (0.79, 0.94) 0.86 (0.79, 0.94) <0.0001
Multivariate HR (95% CI)a 1 0.99 (0.91, 1.07) 0.90 (0.83, 0.98) 0.90 (0.83, 0.98) 0.90 (0.82, 0.98) 0.0002
BMI, body mass index; CI, conﬁdence interval; HR, hazard ratio.
aAdjusted for age, BMI, smoking habit, alcohol consumption, vitamin supplement use, daily walk, weekly physical activity, education level, study area, sleep
disorder, and menopause status (for women).
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was seen in the 5th vs 1st quintiles of vitamin C (HR 0.80; 95%
CI, 0.72–0.88; P for trend < 0.001), vitamin E (HR 0.84; 95% CI,
0.76–0.92; P for trend < 0.001), α-carotene (HR 0.89; 95% CI,
0.80–0.99; P for trend = 0.103), β-carotene (HR 0.87; 95% CI,
0.79–0.96; P for trend = 0.021) and β-cryptoxanthin (HR 0.90;
95% CI, 0.81–0.99; P for trend = 0.004). In women with BMI
<25 kg=m2, reduced mortality risk was seen in the 5th vs 1st
quintiles of vitamin C (HR 0.79; 95% CI, 0.72–0.89; P for
trend < 0.001), vitamin E (HR 0.83; 95% CI, 0.75–0.92; P for
trend < 0.001), β-carotene (HR 0.87; 95% CI, 0.78–0.97; P for
trend = 0.015) and β-cryptoxanthin (HR 0.89; 95% CI, 0.80–
0.99; P for trend = 0.005).
When 1,862 (8.2%) men and 3,530 (9.9%) women who used
daily supplements of multivitamin, vitamin C, or vitamin E were
totally or respectively excluded from the analysis, the results
of the associations between individual or combined antioxidant
nutrients and all-cause mortality were similar to those in Table 2
and Table 3 (data not shown). Exclusion of deaths (476 in men and
326 in women) in the ﬁrst 3 years of follow-up did not substantially
change the ﬁndings. The similar insigniﬁcant associations with
all-cause mortality were observed in men, except the U-shaped
association for β-cryptoxanthin with signiﬁcant association in the
intermediate quintiles (HR 0.90; 95% CI, 0.83–0.98 in the 2nd
quintile, HR 0.87; 95% CI, 0.80–0.95 in the 3rd quintile, and HR
0.88; 95% CI, 0.81–0.95 in the 4th quintile; P for trend = 0.032).
Meanwhile, more strongly signiﬁcant associations for vitamin C,
vitamin E, β-carotene, and β-cryptoxanthin (P for trend < 0.001)
were seen in women (data not shown). In further analysis
stratiﬁed by smoking status, when removing daily vitamin
supplements use, death within the ﬁrst 3 years of follow-up,
or both, these signiﬁcant associations in women nonsmokers
remained, and inverse associations in intermediate quintiles of
β-cryptoxanthin in men was also observed (data not shown).
DISCUSSION
In this large prospective cohort study, increased dietary intakes
of vitamin C, vitamin E, β-carotene, and β-cryptoxanthin were
associated with reduced all-cause mortality in middle-aged
Japanese women. These signiﬁcant inverse associations were
prominently observed in female nonsmokers. These results
provide evidence in Japanese population that is consistent with
the ﬁndings from non-Asian population-based cohort studies
on vitamin C,6,7 vitamin E,10 α-carotene,7 β-carotene,7,10 and β-
Table 3. Joint eﬀects of highly correlated antioxidant nutrients on all-causes mortality in men and women, JACC Study
Dietary intakes of nutrients, mena Dietary intakes of nutrients, womena
Low Others High P, trend Low Others High P, trend
Vitamin C + Vitamin E
Person-years 84,991 200,710 82,367 128,969 335,707 129,079
Number of cases 1,214 3,239 1,726 1,192 2,898 1,265
Age-adjusted HR (95% CI) 1 0.92 (0.86, 0.99) 0.95 (0.88, 1.02) 0.220 1 0.87 (0.81, 0.93) 0.80 (0.74, 0.87) <0.0001
Multivariate HR (95% CI)b 1 0.97 (0.90, 1.03) 1.00 (0.93, 1.08) 0.134 1 0.90 (0.84, 0.96) 0.83 (0.76, 0.90) <0.0001
Vitamin C + α-carotene
Person-years 72,510 222,758 72,799 107,754 372,811 113,190
Number of cases 1,011 3,636 1,532 938 3,235 1,182
Age-adjusted HR (95% CI) 1 0.93 (0.87, 1.00) 0.93 (0.86, 1.01) 0.124 1 0.88 (0.82, 0.94) 0.83 (0.76, 0.90) <0.0001
Multivariate HR (95% CI)b 1 0.96 (0.89, 1.03) 0.97 (0.89, 1.06) 0.049 1 0.89 (0.83, 0.96) 0.85 (0.78, 0.93) <0.0001
Vitamin C + β-carotene
Person-years 80,117 208,166 79,784 123,250 345,035 125,470
Number of cases 1,137 3,377 1,665 1,075 2,984 1,296
Age-adjusted HR (95% CI) 1 0.91 (0.85, 0.97) 0.91 (0.84, 0.98) 0.031 1 0.88 (0.82, 0.94) 0.83 (0.76, 0.90) <0.0001
Multivariate HR (95% CI)b 1 0.94 (0.88, 1.01) 0.96 (0.89, 1.04) 0.013 1 0.91 (0.85, 0.98) 0.87 (0.80, 0.94) <0.0001
Vitamin C + β-cryptoxanthin
Person-years 81,601 201,965 84,502 135,238 328,180 130,337
Number of cases 1,309 3,297 1,573 1,257 2,935 1,163
Age-adjusted HR (95% CI) 1 0.88 (0.83, 0.94) 0.88 (0.81, 0.94) 0.001 1 0.86 (0.80, 0.92) 0.83 (0.77, 0.90) <0.0001
Multivariate HR (95% CI)b 1 0.92 (0.86, 0.98) 0.94 (0.87, 1.02) 0.001 1 0.89 (0.83, 0.95) 0.87 (0.80, 0.95) <0.0001
Vitamin E + α-carotene
Person-years 83,849 202,534 81,684 126,639 335,453 131,663
Number of cases 1,132 3,285 1,762 1,102 2898 1,355
Age-adjusted HR (95% CI) 1 0.98 (0.92, 1.05) 1.02 (0.94, 1.10) 0.550 1 0.89 (0.83, 0.96) 0.86 (0.79, 0.93) 0.0002
Multivariate HR (95% CI)b 1 1.02 (0.95, 1.09) 1.06 (0.98, 1.15) 0.943 1 0.92 (0.86, 0.99) 0.88 (0.81, 0.96) <0.0001
Vitamin E + β-carotene
Person-years 93,870 182,599 91,599 145,702 299,426 148,627
Number of cases 1,300 2,923 1,956 1,277 2,566 1,512
Age-adjusted HR (95% CI) 1 0.94 (0.88, 1.00) 0.97 (0.91, 1.05) 0.647 1 0.88 (0.82, 0.94) 0.83 (0.77, 0.90) <0.0001
Multivariate HR (95% CI)b 1 0.97 (0.91, 1.04) 1.03 (0.95, 1.10) 0.396 1 0.92 (0.86, 0.98) 0.87 (0.80, 0.94) <0.0001
Vitamin E + β-cryptoxanthin
Person-years 59,971 250,192 57,905 92,739 415,926 85,090
Number of cases 896 4,093 1,190 869 3,704 782
Age-adjusted HR (95% CI) 1 0.93 (0.87, 1.00) 0.94 (0.87, 1.03) 0.271 1 0.88 (0.82, 0.95) 0.82 (0.74, 0.90) <0.0001
Multivariate HR (95% CI)b 1 0.97 (0.9, 1.04) 1.01 (0.93, 1.11) 0.223 1 0.93 (0.86, 1.00) 0.87 (0.79, 0.96) <0.0001
CI, conﬁdence interval; HR, hazard ratio.
aLow, all nutrients in tertile 1; high, all nutrients in tertile 3; intermediate, all nutrients in varying tertiles.
bAdjusted for age, body mass index, smoking habit, alcohol consumption, vitamin supplement use, daily walk, weekly physical activity, education level, study
area, sleep disorder, and menopause status (for women).
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cryptoxanthin.7 The inverse associations for individual micro-
nutrients and the strong inverse associations for combined dietary
intakes of antioxidants may represent joint eﬀects of highly
correlated micronutrients.28
Dietary intakes of vitamin C, vitamin E, and β-carotene were
higher in women than those in men in this study. Men tend to
underreport their dietary intake when it is ascertained through a
FFQ,29 and women might recall dietary habits better than men,
given their traditional roles in buying food and cooking.2
For dietary habit, individuals who consume more fruits and
vegetables may also consume less dietary fat or may be more
health-conscious in other ways than individuals who consume
relatively few fruits and vegetables.30 This may be related to the
better micronutrient density usually observed in women than in
men and to risky lifestyles observed more in men than in women,
such as smoking, drinking alcoholic beverages, or being
Table 4. Associations between energy-adjusted dietary antioxidant nutrients and all-cause mortality in men of current, former and never
smokers, JACC Study
HR (95% CI) by quintile intakes of nutrientsa
P, trend
Q2 Q3 Q4 Q5
Current smokers
Vitamin C
Age-adjusted 0.94 (0.85, 1.04) 0.92 (0.83, 1.02) 0.91 (0.82, 1.00) 0.97 (0.87, 1.07) 0.498
Multivariateb 0.95 (0.86, 1.05) 0.94 (0.85, 1.04) 0.93 (0.84, 1.03) 0.98 (0.89, 1.09) 0.730
Vitamin E
Age-adjusted 0.92 (0.83, 1.02) 0.96 (0.86, 1.06) 0.91 (0.83, 1.01) 1.01 (0.92, 1.12) 0.686
Multivariateb 0.93 (0.84, 1.03) 0.97 (0.87, 1.07) 0.92 (0.83, 1.02) 1.01 (0.91, 1.12) 0.763
α-carotene
Age-adjusted 0.97 (0.87, 1.08) 0.95 (0.86, 1.05) 0.98 (0.89, 1.09) 1.01 (0.91, 1.12) 0.573
Multivariateb 0.97 (0.87, 1.08) 0.96 (0.86, 1.06) 0.97 (0.87, 1.07) 0.99 (0.90, 1.10) 0.912
β-carotene
Age-adjusted 1.02 (0.92, 1.13) 0.95 (0.85, 1.05) 0.98 (0.88, 1.08) 1.03 (0.93, 1.14) 0.720
Multivariateb 1.02 (0.92, 1.13) 0.96 (0.86, 1.06) 0.99 (0.89, 1.10) 1.01 (0.91, 1.12) 0.960
β-cryptoxanthin
Age-adjusted 0.91 (0.83, 1.00) 0.84 (0.76, 0.93) 0.85 (0.77, 0.93) 0.98 (0.89, 1.08) 0.601
Multivariateb 0.92 (0.84, 1.02) 0.86 (0.78, 0.95) 0.86 (0.78, 0.95) 1.01 (0.92, 1.12) 0.992
Former smokers
Vitamin C
Age-adjusted 0.85 (0.72, 1.00) 0.85 (0.73, 1.00) 0.87 (0.75, 1.01) 0.92 (0.79, 1.06) 0.707
Multivariateb 0.87 (0.74, 1.02) 0.88 (0.75, 1.03) 0.90 (0.77, 1.05) 0.94 (0.81, 1.09) 0.937
Vitamin E
Age-adjusted 0.93 (0.78, 1.10) 0.87 (0.74, 1.03) 0.97 (0.83, 1.13) 1.02 (0.88, 1.19) 0.284
Multivariateb 0.94 (0.79, 1.11) 0.87 (0.74, 1.02) 0.97 (0.82, 1.14) 1.01 (0.86, 1.18) 0.438
α-carotene
Age-adjusted 1.02 (0.86, 1.21) 1.10 (0.93, 1.30) 0.99 (0.84, 1.16) 1.20 (1.03, 1.41) 0.012
Multivariateb 1.03 (0.87, 1.22) 1.11 (0.94, 1.31) 0.98 (0.83, 1.15) 1.15 (0.98, 1.34) 0.104
β-carotene
Age-adjusted 1.01 (0.85, 1.20) 1.02 (0.86, 1.20) 0.94 (0.80, 1.11) 1.03 (0.88, 1.21) 0.823
Multivariateb 1.00 (0.84, 1.19) 1.03 (0.87, 1.21) 0.94 (0.79, 1.10) 1.00 (0.85, 1.17) 0.799
β-cryptoxanthin
Age-adjusted 0.87 (0.74, 1.01) 0.82 (0.71, 0.96) 0.87 (0.75, 1.01) 0.85 (0.74, 0.99) 0.139
Multivariateb 0.88 (0.76, 1.03) 0.81 (0.70, 0.95) 0.89 (0.77, 1.04) 0.88 (0.76, 1.02) 0.325
Never smokers
Vitamin C
Age-adjusted 0.97 (0.78, 1.20) 0.91 (0.74, 1.13) 1.00 (0.81, 1.22) 0.95 (0.78, 1.16) 0.787
Multivariateb 0.98 (0.79, 1.22) 0.93 (0.75, 1.15) 1.02 (0.83, 1.25) 0.96 (0.78, 1.17) 0.810
Vitamin E
Age-adjusted 0.92 (0.74, 1.15) 1.02 (0.83, 1.27) 0.95 (0.77, 1.18) 1.00 (0.82, 1.22) 0.764
Multivariateb 0.93 (0.75, 1.16) 1.03 (0.83, 1.27) 0.98 (0.79, 1.21) 1.01 (0.83, 1.23) 0.708
α-carotene
Age-adjusted 0.92 (0.73, 1.16) 0.96 (0.77, 1.20) 1.14 (0.92, 1.42) 1.09 (0.88, 1.34) 0.073
Multivariateb 0.92 (0.73, 1.16) 0.96 (0.77, 1.21) 1.12 (0.90, 1.39) 1.04 (0.84, 1.29) 0.235
β-carotene
Age-adjusted 0.90 (0.72, 1.13) 1.04 (0.84, 1.29) 0.87 (0.71, 1.08) 1.01 (0.82, 1.23) 0.778
Multivariateb 0.95 (0.76, 1.19) 1.07 (0.86, 1.32) 0.89 (0.72, 1.10) 1.02 (0.83, 1.25) 0.927
β-cryptoxanthin
Age-adjusted 0.85 (0.70, 1.04) 0.91 (0.75, 1.10) 0.88 (0.73, 1.07) 0.95 (0.78, 1.15) 0.996
Multivariateb 0.85 (0.70, 1.04) 0.91 (0.75, 1.11) 0.91 (0.75, 1.10) 0.96 (0.79, 1.16) 0.828
CI, conﬁdence interval; HR, hazard ratio.
aThe lowest quintile (Q1) was used as the reference category (HR = 1).
bAdjusted for age, body mass index, alcohol consumption, vitamin supplement use, daily walk, weekly physical activity, education level, study area, and sleep
disorder.
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overweight, which are known to decrease β-carotene and vitamin
C serum levels.31 Although these variables were adjusted in the
analyses, residual confounders or unmeasured variables could
account for the discrepancy. The higher mortality from CVD
and non-hormone-dependent cancers in Japanese men compared
with women14,19 might be partially explain the disparities
of associations observed in men and women in this study
population. The JACC Study reported the inverse associations of
dietary intakes of vitamins C and E with mortality from CVD,14
dietary intake of α-carotene with mortality from prostate cancer,32
and serum carotenes with mortality from all cancer,18 colorectal
cancer,18 and lung cancer.33 However, the associations of
antioxidant nutrient intakes with mortality from all cancer and
many other types of cancer need to be further investigated in the
JACC Study.18,32 Combining all cancer sites may dilute the
observed associations regarding speciﬁc cancers, and the
Table 5. Associations between energy-adjusted dietary antioxidant nutrients and all-cause mortality in women of current, former and
never smokers, JACC Study
HR (95% CI) by quintile intakes of nutrientsa
P, trend
Q2 Q3 Q4 Q5
Current smokers
Vitamin C
Age-adjusted 0.91 (0.67, 1.22) 0.79 (0.57, 1.10) 0.63 (0.45, 0.88) 0.87 (0.64, 1.16) 0.092
Multivariateb 0.90 (0.67, 1.22) 0.83 (0.59, 1.15) 0.64 (0.45, 0.91) 0.88 (0.65, 1.19) 0.130
Vitamin E
Age-adjusted 0.94 (0.70, 1.26) 0.93 (0.67, 1.30) 0.92 (0.67, 1.26) 0.92 (0.68, 1.26) 0.563
Multivariateb 0.94 (0.70, 1.27) 0.93 (0.66, 1.30) 0.92 (0.67, 1.27) 0.90 (0.66, 1.23) 0.487
α-carotene
Age-adjusted 0.76 (0.56, 1.05) 0.91 (0.66, 1.24) 0.95 (0.70, 1.29) 0.88 (0.64, 1.21) 0.784
Multivariateb 0.81 (0.59, 1.12) 0.91 (0.66, 1.25) 0.93 (0.68, 1.27) 0.87 (0.63, 1.19) 0.574
β-carotene
Age-adjusted 0.84 (0.62, 1.15) 1.12 (0.82, 1.52) 0.70 (0.49, 1.00) 0.96 (0.71, 1.29) 0.631
Multivariateb 0.86 (0.63, 1.17) 1.11 (0.81, 1.52) 0.73 (0.51, 1.05) 0.95 (0.70, 1.29) 0.615
β-cryptoxanthin
Age-adjusted 0.94 (0.69, 1.27) 0.79 (0.57, 1.10) 0.75 (0.54, 1.03) 0.81 (0.60, 1.09) 0.080
Multivariateb 0.89 (0.65, 1.22) 0.83 (0.59, 1.15) 0.79 (0.57, 1.10) 0.83 (0.61, 1.12) 0.169
Former smokers
Vitamin C
Age-adjusted 0.83 (0.47, 1.48) 0.87 (0.48, 1.56) 1.00 (0.58, 1.73) 0.72 (0.40, 1.29) 0.443
Multivariateb 0.90 (0.50, 1.63) 0.83 (0.45, 1.52) 0.96 (0.55, 1.70) 0.67 (0.36, 1.24) 0.282
Vitamin E
Age-adjusted 1.23 (0.69, 2.21) 1.07 (0.60, 1.93) 1.05 (0.62, 1.78) 0.73 (0.43, 1.25) 0.111
Multivariateb 1.30 (0.71, 2.38) 1.11 (0.60, 2.07) 1.08 (0.62, 1.88) 0.65 (0.37, 1.16) 0.128
α-carotene
Age-adjusted 1.00 (0.55, 1.82) 1.07 (0.57, 1.99) 1.29 (0.69, 2.41) 1.03 (0.56, 1.86) 0.036
Multivariateb 0.84 (0.45, 1.57) 0.73 (0.37, 1.42) 1.33 (0.69, 2.56) 0.71 (0.38, 1.34) 0.548
β-carotene
Age-adjusted 1.25 (0.71, 2.19) 0.68 (0.35, 1.30) 1.02 (0.57, 1.82) 0.47 (0.23, 0.98) 0.030
Multivariateb 0.64 (0.33, 1.22) 1.01 (0.54, 1.86) 1.01 (0.55, 1.84) 0.63 (0.34, 1.18) 0.399
β-cryptoxanthin
Age-adjusted 0.78 (0.42, 1.44) 1.13 (0.63, 2.01) 1.04 (0.58, 1.85) 0.83 (0.47, 1.49) 0.802
Multivariateb 0.88 (0.51, 1.52) 0.76 (0.41, 1.39) 1.04 (0.58, 1.87) 0.71 (0.39, 1.26) 0.333
Never smokers
Vitamin C
Age-adjusted 0.89 (0.81, 0.98) 0.89 (0.81, 0.97) 0.84 (0.77, 0.92) 0.84 (0.77, 0.91) <0.0001
Multivariateb 0.91 (0.83, 0.99) 0.92 (0.84, 1.00) 0.89 (0.81, 0.97) 0.88 (0.80, 0.96) 0.005
Vitamin E
Age-adjusted 0.86 (0.78, 0.94) 0.85 (0.78, 0.93) 0.84 (0.77, 0.92) 0.82 (0.75, 0.89) <0.0001
Multivariateb 0.88 (0.80, 0.96) 0.88 (0.81, 0.96) 0.88 (0.80, 0.96) 0.85 (0.78, 0.92) 0.001
α-carotene
Age-adjusted 0.99 (0.90, 1.09) 0.92 (0.84, 1.01) 0.93 (0.85, 1.02) 0.95 (0.87, 1.04) 0.285
Multivariateb 0.99 (0.90, 1.09) 0.93 (0.84, 1.02) 0.92 (0.84, 1.01) 0.96 (0.87, 1.05) 0.275
β-carotene
Age-adjusted 0.87 (0.79, 0.96) 0.88 (0.80, 0.96) 0.80 (0.73, 0.87) 0.89 (0.81, 0.97) 0.012
Multivariateb 0.88 (0.80, 0.97) 0.89 (0.82, 0.98) 0.83 (0.76, 0.91) 0.91 (0.83, 0.99) 0.062
β-cryptoxanthin
Age-adjusted 0.97 (0.89, 1.06) 0.87 (0.80, 0.95) 0.91 (0.83, 0.99) 0.89 (0.82, 0.98) 0.004
Multivariateb 0.98 (0.90, 1.07) 0.91 (0.83, 0.99) 0.95 (0.87, 1.04) 0.93 (0.85, 1.02) 0.098
CI, conﬁdence interval; HR, hazard ratio.
aThe lowest quintile (Q1) was used as the reference category (HR = 1).
bAdjusted for age, body mass index, alcohol consumption, vitamin supplement use, daily walk, weekly physical activity, education level, study area, sleep
disorder, and menopause status.
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protective eﬀect on all-cause mortality from dietary intakes of
antioxidant nutrients may be mainly dependent on reductions in
CVD mortality rather than cancer mortality.9
A Spanish study reported signiﬁcant lower mortality in those
with higher dietary β-cryptoxanthin intake,7 and, in a Dutch
elderly population, signiﬁcantly higher risk of all-cause mortality
was observed in the lower serum β-cryptoxanthin group.34 Beta-
cryptoxanthin, lutein, and zeaxanthin are oxygenated carote-
noids.34 In our study, the U-shaped association between the dietary
intake of β-cryptoxanthin and all-cause mortality in men and null
results of an α-carotene-mortality relationship in women may
indicate the complex mechanism of carotenoids in antioxidant
activities. For instance, β-cryptoxanthin scavenges for free radicals
in a polar environment, while α-carotene clears more deep in the
lipoprotein cell membrane layer.35 It is also possible that carotenes
are potentially acting as markers for other correlated etiologic
factors.30,36 It is unclear when these dietary components are most
eﬀective in the prevention of disease, although we did not observe
any signiﬁcant interaction eﬀects among studied micronutrients.
Whether there is a threshold or dose-response eﬀect, or even a
triage eﬀect from carotenoids, may depend on particular outcomes
of diseases, including CVD, cancer, metabolic syndrome, or
dysglycemia.37 Nevertheless, these diﬀerent ﬁndings among
studies might be due to the disparities of study design, populations,
main causes of death, and also food sources or components.38,39
Smoking increases the utilization of antioxidant micronutrients
on the basis of increased oxidative stress, which contributes to the
low plasma antioxidant concentration.40 The increased oxidative
stress enhances the possibility of gene mutations, oxidization of
lipids and proteins, and alteration of signal transduction pathways
that damage cells.41,42 Our study results were consistent with
other reports that the dietary intakes of vitamin C, vitamin E, and
α- and β-carotene were higher in nonsmokers than in smokers.43
A study in French women showed that, in never smokers,
increasing dietary β-carotene intake was associated with a
decreased risk of tobacco-related cancer.44 Smoking causes
oxidative damage in organs, so smokers may beneﬁt from intake
of foods rich in antioxidant for reducing the risk of disease
occurrences.11 However, in our study, those insigniﬁcant
associations both in male and female smokers=former smokers
also indicated that the protective eﬀect of antioxidant micro-
nutrients may not be strong enough to counteract the increased
oxidative stress from tobacco smoking.45 Dietary modiﬁcation
should not be considered a substitute for smoking prevention.25
In this study population, the daily use of vitamin supplement
(8.2% in men and 9.9% in women) was lower than in other
populations (eg, 61–68% in the United States).6 Carotenoids,
such as β-carotene, may have a possible biphasic response that
promotes health when taken at dietary levels but may have
adverse eﬀects when taken in higher amounts.38 Dietary
supplements of some carotenoids have been associated with
increased risks of degenerative diseases46 and lung cancer.47
Studies also found consistent evidence of deleterious eﬀects on
all-cause mortality for dietary supplements containing vitamin A,
vitamin E, and=or β-carotene.10,48 The similar signiﬁcant inverse
associations observed after removing the daily vitamin supple-
ment in this study elucidated that the signiﬁcant associations
of nutrient intakes and all-cause mortality were driven by basic
dietary intakes rather than supplements.
The strengths of this study include its prospective cohort design,
a large number of deaths during a long follow-up time with
suﬃcient statistical power, multiple adjustments for relevant
confounders, and evaluation of an Asian population. The
limitations of this study warrant discussion. First, we used an
FFQ with only 33 food items to identify intakes of antioxidants,
and we used death certiﬁcates to deﬁne events. The validity of
FFQ for intakes of antioxidant vitamins with diet record was not
high, and we did not have data about vitamin E and carotene in
the validation study.22 However, the diet misclassiﬁcation would
attenuate ﬁndings toward the null in this study, since it is unlikely
to be related to the baseline intakes of antioxidant vitamins.
Second, the exclusion of missing dietary information may aﬀect
generalizability, although it may not greatly aﬀect the signiﬁcant
ﬁndings in this study.22 Third, the possibility of other confounding
by unmeasured or incompletely adjusted all-cause mortality
risk factors also applies to this study, including the residual
confounding by smoking.25,36 Fourth, because we only conducted
a FFQ survey for baseline dietary intake, changes in vitamin
intakes over time were not accessed to examine temporal aspects.27
Results of this study suggest that dietary intakes of vitamin C,
vitamin E, β-carotene, and β-cryptoxanthin were inversely
associated with all-cause mortality in Japanese women. These
ﬁndings are consistent with the notion that intake of fruits and
vegetables that are rich in dietary antioxidant micronutrients may
be independently or jointly protective against all-cause mortality,
particularly in female nonsmokers. Further studies on modiﬁed
eﬀects from lifestyle factors on the nutrient-mortality relationship
are needed.
ACKNOWLEDGEMENTS
The JACC Study has been supported by Grants-in-Aid for
Scientiﬁc Research from the Ministry of Education, Science,
Sports and Culture of Japan (Monbu Kagaku-sho), Tokyo (nos.
61010076, 2010074, 63010074, 1010068, 2151065, 3151064,
4151063, 5151069, 6279102, 11181101, 17015022, 18014011
and 16H06277) and by Grant-in-Aid from the Ministry of Health,
Labour and Welfare, Health and Labor Sciences Research Grants,
Japan (H23-Junkankitou [Seishuu]-Ippan-005, H26-Junkankitou
[Seisaku]-Ippan-001 and H29-Junkankitou [Seishuu]-Ippan-003).
The authors thank all members of the Japan Collaborative
Cohort Study, which can be found in detail at http:==
publichealth.med.hokudai.ac.jp=jacc=member.html.
Conﬂicts of interest: None declared.
REFERENCES
1. Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the
epidemiological evidence for the ‘antioxidant hypothesis’. Public
Health Nutr. 2004;7:407–422.
2. Paganini-Hill A, Kawas CH, Corrada MM. Antioxidant vitamin
intake and mortality: the Leisure World Cohort Study. Am J
Epidemiol. 2015;181:120–126.
3. Traber MG, Stevens JF. Vitamins C and E: beneﬁcial eﬀects from a
mechanistic perspective. Free Radic Biol Med. 2011;51:1000–1013.
4. Kong SY, Goodman M, Judd S, Bostick RM, Flanders WD,
McClellan W. Oxidative balance score as predictor of all-cause,
cancer, and noncancer mortality in a biracial US cohort. Ann
Epidemiol. 2015;25:256–262.e1.
5. Stepaniak U, Micek A, Grosso G, et al. Antioxidant vitamin intake
and mortality in three Central and Eastern European urban
populations: the HAPIEE study. Eur J Nutr. 2016;55:547–560.
6. Sahyoun NR, Jacques PF, Russell RM. Carotenoids, vitamins C and
E, and mortality in an elderly population. Am J Epidemiol.
Ma E, et al.
J Epidemiol 2018;28(9):388-396 j 395
1996;144:501–511.
7. Agudo A, Cabrera L, Amiano P, et al. Fruit and vegetable intakes,
dietary antioxidant nutrients, and total mortality in Spanish adults:
ﬁndings from the Spanish cohort of the European Prospective
Investigation into Cancer and Nutrition (EPIC-Spain). Am J Clin
Nutr. 2007;85:1634–1642.
8. Bates CJ, Hamer M, Mishra GD. Redox-modulatory vitamins and
minerals that prospectively predict mortality in older British people:
the National Diet and Nutrition Survey of people aged 65 years and
over. Br J Nutr. 2011;105:123–132.
9. Zhao LG, Shu XO, Li HL, et al. Dietary antioxidant vitamins intake
and mortality: a report from two cohort studies of Chinese adults in
Shanghai. J Epidemiol. 2017;27:89–97.
10. Roswall N, Olsen A, Christensen J, et al. Micronutrient intake in
relation to all-cause mortality in a prospective Danish cohort. Food
Nutr Res. 2012;56.
11. Van Hoydonck PG, Temme EH, Schouten EG. A dietary oxidative
balance score of vitamin C, beta-carotene and iron intakes and
mortality risk in male smoking Belgians. J Nutr. 2002;132:756–761.
12. Genkinger JM, Platz EA, Hoﬀman SC, Comstock GW, Helzlsouer
KJ. Fruit, vegetable, and antioxidant intake and all-cause, cancer,
and cardiovascular disease mortality in a community-dwelling
population in Washington County, Maryland. Am J Epidemiol.
2004;160:1223–1233.
13. Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C. Dietary
antioxidant vitamins and ﬁber in the etiology of cardiovascular
disease and all-causes mortality: results from the Scottish Heart
Health Study. Am J Epidemiol. 1999;150:1073–1080.
14. Kubota Y, Iso H, Date C, et al; JACC Study Group. Dietary intakes
of antioxidant vitamins and mortality from cardiovascular disease:
the Japan Collaborative Cohort Study (JACC) study. Stroke.
2011;42:1665–1672.
15. Iso H, Kubota Y; Japan Collaborative Cohort Study for Evaluation
of Cancer. Nutrition and disease in the Japan Collaborative Cohort
Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev.
2007;8(Suppl):35–80.
16. Kobylecki CJ, Afzal S, Davey Smith G, Nordestgaard BG.
Genetically high plasma vitamin C, intake of fruit and vegetables,
and risk of ischemic heart disease and all-cause mortality: a
Mendelian randomization study. Am J Clin Nutr. 2015;101:1135–
1143.
17. Ito Y, Suzuki K, Suzuki S, Sasaki R, Otani M, Aoki K. Serum
antioxidants and subsequent mortality rates of all causes or cancer
among rural Japanese inhabitants. Int J Vitam Nutr Res. 2002;
72:237–250.
18. Ito Y, Suzuki K, Ishii J, et al. A population-based follow-up study on
mortality from cancer or cardiovascular disease and serum
carotenoids, retinol and tocopherols in Japanese inhabitants. Asian
Pac J Cancer Prev. 2006;7:533–546.
19. Tamakoshi A, Ozasa K, Fujino Y, et al; JACC Study Group. Cohort
proﬁle of the Japan Collaborative Cohort Study at ﬁnal follow-up.
J Epidemiol. 2013;23:227–232.
20. Tamakoshi A, Yoshimura T, Inaba Y, et al; JACC Study Group.
Proﬁle of the JACC study. J Epidemiol. 2005;15(Suppl 1):S4–S8.
21. Willet W. Issues in analysis and presentation of dietary data.
In: Willet W, editor. Nutritional Epidemiology. Oxford: Oxford
University Press; 1998. p. 321–347.
22. Date C, Fukui M, Yamamoto A, et al; JACC Study Group.
Reproducibility and validity of a self-administered food frequency
questionnaire used in the JACC study. J Epidemiol. 2005;15
(Suppl 1):S9–S23.
23. Science and Technology Agency of Japan. Ministry of Education,
Culture, Sports, Science and Technology, the Government of Japan.
Standard tables of food composition in Japan, the ﬁfth revised and
enlarged edition. Tokyo: Printing Bureau, Ministry of Finance; 2005.
24. Willett WC, Howe GR, Kushi LH. Adjustment for total energy
intake in epidemiologic studies. Am J Clin Nutr. 1997;65(4)
(Suppl):1220S–1228S; discussion 1229S–1231S.
25. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. Dietary
carotenoids, serum beta-carotene, and retinol and risk of lung cancer
in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol.
2002;156:536–547.
26. Yong LC, Brown CC, Schatzkin A, et al. Intake of vitamins E, C,
and A and risk of lung cancer. The NHANES I epidemiologic
followup study. First National Health and Nutrition Examination
Survey. Am J Epidemiol. 1997;146:231–243.
27. Michaud DS, Feskanich D, Rimm EB, et al. Intake of speciﬁc
carotenoids and risk of lung cancer in 2 prospective US cohorts. Am
J Clin Nutr. 2000;72:990–997.
28. van Poppel G, Goldbohm RA. Epidemiologic evidence for beta-
carotene and cancer prevention. Am J Clin Nutr. 1995;62(6)(Suppl):
1393S–1402S.
29. Gnardellis C, Boulou C, Trichopoulou A. Magnitude, determinants
and impact of under-reporting of energy intake in a cohort study in
Greece. Public Health Nutr. 1998;1:131–137.
30. Mayne ST. Beta-carotene, carotenoids, and disease prevention in
humans. FASEB J. 1996;10:690–701.
31. Galan P, Viteri FE, Bertrais S, et al. Serum concentrations of beta-
carotene, vitamins C and E, zinc and selenium are inﬂuenced by sex,
age, diet, smoking status, alcohol consumption and corpulence in a
general French adult population. Eur J Clin Nutr. 2005;59:1181–
1190.
32. Umesawa M, Iso H, Mikami K, et al; JACC Study Group.
Relationship between vegetable and carotene intake and risk of
prostate cancer: the JACC study. Br J Cancer. 2014;110:792–796.
33. Ito Y, Wakai K, Suzuki K, et al; JACC Study Group. Serum
carotenoids and mortality from lung cancer: a case-control study
nested in the Japan Collaborative Cohort (JACC) study. Cancer Sci.
2003;94:57–63.
34. De Waart FG, Schouten EG, Stalenhoef AF, Kok FJ. Serum
carotenoids, alpha-tocopherol and mortality risk in a prospective
study among Dutch elderly. Int J Epidemiol. 2001;30:136–143.
35. El-Agamey A, Lowe GM, McGarvey DJ, et al. Carotenoid radical
chemistry and antioxidant=pro-oxidant properties. Arch Biochem
Biophys. 2004;430:37–48.
36. Gallicchio L, Boyd K, Matanoski G, et al. Carotenoids and the risk
of developing lung cancer: a systematic review. Am J Clin Nutr.
2008;88:372–383.
37. Donaldson MS. A carotenoid health index based on plasma
carotenoids and health outcomes. Nutrients. 2011;3:1003–1022.
38. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res.
2007;55:207–216.
39. Fairﬁeld KM, Fletcher RH. Vitamins for chronic disease prevention
in adults: scientiﬁc review. JAMA. 2002;287:3116–3126.
40. Cross CE, Traber M, Eiserich J, van der Vliet A. Micronutrient
andtioxidants and smoking. Br Med Bull. 1999;55:691–704.
41. Pryor WA. Cigarette smoke radicals and the role of free radicals
in chemical carcinogenicity. Environ Health Perspect. 1997;105
(Suppl 4):875–882.
42. Borek C. Dietary antioxidants and human cancer. Integr Cancer
Ther. 2004;3:333–341.
43. Yuan JM, Stram DO, Arakawa K, Lee HP, Yu MC. Dietary
cryptoxanthin and reduced risk of lung cancer: the Singapore
Chinese Health Study. Cancer Epidemiol Biomarkers Prev. 2003;
12:890–898.
44. Touvier M, Kesse E, Clavel-Chapelon F, Boutron-Ruault MC. Dual
association of beta-carotene with risk of tobacco-related cancers in a
cohort of French women. J Natl Cancer Inst. 2005;97:1338–1344.
45. Loria CM, Klag MJ, Caulﬁeld LE, Whelton PK. Vitamin C status
and mortality in US adults. Am J Clin Nutr. 2000;72:139–145.
46. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of
antioxidant vitamins for the prevention of cardiovascular disease:
meta-analysis of randomised trials. Lancet. 2003;361:2017–2023.
47. Omenn GS, Goodman GE, Thornquist MD, et al. Eﬀects of a
combination of beta carotene and vitamin A on lung cancer and
cardiovascular disease. N Engl J Med. 1996;334:1150–1155.
48. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C.
Antioxidant supplements for prevention of mortality in healthy
participants and patients with various diseases. Cochrane Database
Syst Rev. 2008;CD007176.
Dietary Micronutrients and All-Cause Mortality
396 j J Epidemiol 2018;28(9):388-396
